_version_ 1784730628098359296
author Quan, Joshua
Ma, Christopher
Panaccione, Remo
Kanji, Jamil
Charlton, Carmen
Tipples, Graham
Sharifi, Nastaran
Herauf, Michelle
Markovinovic, Ante
Turnbull, LeeAnn
Bernatsky, Sasha
Bindra, Gurmeet K.
Mahoney, Douglas
Ingram, Richard J.
Hracs, Lindsay
Coward, Stephanie
Windsor, Joseph W.
Buie, Michael J.
Chan, Melissa
Ferraz, Jose G.
Lu, Cathy
Mathivanan, Meena
Novak, Kerri L.
Seow, Cynthia H.
Shukla, Tushar
Kaplan, Gilaad
author_facet Quan, Joshua
Ma, Christopher
Panaccione, Remo
Kanji, Jamil
Charlton, Carmen
Tipples, Graham
Sharifi, Nastaran
Herauf, Michelle
Markovinovic, Ante
Turnbull, LeeAnn
Bernatsky, Sasha
Bindra, Gurmeet K.
Mahoney, Douglas
Ingram, Richard J.
Hracs, Lindsay
Coward, Stephanie
Windsor, Joseph W.
Buie, Michael J.
Chan, Melissa
Ferraz, Jose G.
Lu, Cathy
Mathivanan, Meena
Novak, Kerri L.
Seow, Cynthia H.
Shukla, Tushar
Kaplan, Gilaad
author_sort Quan, Joshua
collection PubMed
description
format Online
Article
Text
id pubmed-9212568
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AGA Institute. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92125682022-06-22 Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY Quan, Joshua Ma, Christopher Panaccione, Remo Kanji, Jamil Charlton, Carmen Tipples, Graham Sharifi, Nastaran Herauf, Michelle Markovinovic, Ante Turnbull, LeeAnn Bernatsky, Sasha Bindra, Gurmeet K. Mahoney, Douglas Ingram, Richard J. Hracs, Lindsay Coward, Stephanie Windsor, Joseph W. Buie, Michael J. Chan, Melissa Ferraz, Jose G. Lu, Cathy Mathivanan, Meena Novak, Kerri L. Seow, Cynthia H. Shukla, Tushar Kaplan, Gilaad Gastroenterology AGA Abstracts AGA Institute. Published by Elsevier Inc. 2022-05 2022-06-16 /pmc/articles/PMC9212568/ http://dx.doi.org/10.1016/S0016-5085(22)61406-9 Text en Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle AGA Abstracts
Quan, Joshua
Ma, Christopher
Panaccione, Remo
Kanji, Jamil
Charlton, Carmen
Tipples, Graham
Sharifi, Nastaran
Herauf, Michelle
Markovinovic, Ante
Turnbull, LeeAnn
Bernatsky, Sasha
Bindra, Gurmeet K.
Mahoney, Douglas
Ingram, Richard J.
Hracs, Lindsay
Coward, Stephanie
Windsor, Joseph W.
Buie, Michael J.
Chan, Melissa
Ferraz, Jose G.
Lu, Cathy
Mathivanan, Meena
Novak, Kerri L.
Seow, Cynthia H.
Shukla, Tushar
Kaplan, Gilaad
Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title_full Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title_fullStr Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title_full_unstemmed Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title_short Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
title_sort su1484: serological responses to sars-cov-2 vaccination in patients with inflammatory bowel disease: a prospective cohort study
topic AGA Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9212568/
http://dx.doi.org/10.1016/S0016-5085(22)61406-9
work_keys_str_mv AT quanjoshua su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT machristopher su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT panaccioneremo su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT kanjijamil su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT charltoncarmen su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT tipplesgraham su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT sharifinastaran su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT heraufmichelle su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT markovinovicante su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT turnbullleeann su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT bernatskysasha su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT bindragurmeetk su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT mahoneydouglas su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT ingramrichardj su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT hracslindsay su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT cowardstephanie su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT windsorjosephw su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT buiemichaelj su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT chanmelissa su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT ferrazjoseg su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT lucathy su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT mathivananmeena su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT novakkerril su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT seowcynthiah su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT shuklatushar su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy
AT kaplangilaad su1484serologicalresponsestosarscov2vaccinationinpatientswithinflammatoryboweldiseaseaprospectivecohortstudy